CD36 and malaria: Furthermore, RXR agonists, which upregulate CD36 expression through direct promoter interactions, were shown to induce an increase in CD36-mediated phagocytosis and a decrease in malaria-induced TNF-α secretion by human monocytes and macrophages [39,40].